These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 14968413
1. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ. Cancer; 2004 Feb 25; 102(1):11-8. PubMed ID: 14968413 [Abstract] [Full Text] [Related]
3. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions. Zhou F, Pulinthanathu R, Elgert P, Cangiarella J, Simsir A. Diagn Cytopathol; 2015 May 25; 43(5):381-7. PubMed ID: 25546355 [Abstract] [Full Text] [Related]
6. Cytology versus HPV testing for cervical cancer screening in the general population. Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M. Cochrane Database Syst Rev; 2017 Aug 10; 8(8):CD008587. PubMed ID: 28796882 [Abstract] [Full Text] [Related]
7. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. Cancer Epidemiol Biomarkers Prev; 2008 May 10; 17(5):1248-54. PubMed ID: 18483347 [Abstract] [Full Text] [Related]
8. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G. Mod Pathol; 2001 Jul 10; 14(7):702-9. PubMed ID: 11455003 [Abstract] [Full Text] [Related]
12. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia. Voss JS, Kipp BR, Campion MB, Sokolova IA, Henry MR, Halling KC, Clayton AC. Anal Quant Cytol Histol; 2010 Jun 10; 32(3):121-30. PubMed ID: 20701064 [Abstract] [Full Text] [Related]
13. Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques. Zehbe I, Rylander E, Edlund K, Wadell G, Wilander E. Virchows Arch; 1996 Jun 10; 428(3):151-7. PubMed ID: 8688969 [Abstract] [Full Text] [Related]
16. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status]. Li TY, Wu ZN, Jiang MY, Cui JF, Liu B, Chen F, Chen W. Zhonghua Zhong Liu Za Zhi; 2018 Jun 23; 40(6):475-480. PubMed ID: 29936777 [Abstract] [Full Text] [Related]
17. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL. Int J Cancer; 2010 Sep 01; 127(5):1151-7. PubMed ID: 20039323 [Abstract] [Full Text] [Related]
20. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920 [Abstract] [Full Text] [Related] Page: [Next] [New Search]